Page last updated: 2024-09-03

procyanidin b2 and Squamous Cell Carcinoma of Head and Neck

procyanidin b2 has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Mei, B; Sun, Q; Xiao, Q; Zhang, T; Zhang, X	1

Other Studies

1 other study(ies) available for procyanidin b2 and Squamous Cell Carcinoma of Head and Neck

Article	Year
Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway. Bioengineered, 2022, Volume: 13, Issue:3 Topics: Biflavonoids; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Mouth Neoplasms; Neovascularization, Pathologic; Proanthocyanidins; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2022

Article

Year

Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway.

Bioengineered, 2022, Volume: 13, Issue:3

Topics: Biflavonoids; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Mouth Neoplasms; Neovascularization, Pathologic; Proanthocyanidins; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2022